Drug‐Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data Sources

Documenti analoghi

• The Persistent Ambiguity of Adverse Drug Reactions
  di: Edward M. Sellers, et al.
  Pubblicazione: (2025)
• Discovering Severe Adverse Reactions From Pharmacokinetic Drug–Drug Interactions Through Literature Analysis and Electronic Health Record Verification
  di: Eugene Jeong, et al.
  Pubblicazione: (2024)
• The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics‐Based Clinical Guidelines
  di: Janine Scholefield, et al.
  Pubblicazione: (2026)
• Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data
  di: Natalia Sauer, et al.
  Pubblicazione: (2026)
• Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions
  di: Leila Potzel, et al.
  Pubblicazione: (2026)